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corresponds to two standard deviations. The therapeutic decision about the treatment technique involves improvements or
worsening of some parameters that can inﬂuence clinical outcomes and the choice will be taken by the radiation oncologist.
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Introduction. Gamma Knife is an irradiation device with 192 60Co sources, whose beams converge on one point. It is used with
a stereotactic frame ﬁxed to the patient’s skull that provides radiation delivery with submillimetric precision and accuracy and
a steep dose gradient. These quality parameters are maintained even with very small collimators (4mm). On the other hand,
trigeminal neuralgia is an extremely disabling, and often refractory to medical treatment, facial pain disorder.
Material and methods. We analyze the evolution of radiosurgery and Gamma Knife units from the early days to the current
Gamma KnifePerfexion®, as well as the workﬂow, indications for treatment and quality control requirements. We will focus on its
application in functional neurosurgery, speciﬁcally in trigeminal neuralgia treatment, reviewing treatment planning, dosimetry,
and quality control, as well as the clinical outcomes.
Results. The equipment has a mechanical accuracy of less than 0.4mm, with a current measured accuracy of 0.1mm, and repro-
ducibility of <0.01mm. As for the automatic positioning system, the linear motion and rotation controls guarantee the correct
position with a reproducibility of <0.05. Clinical results are analyzed in 117 patient treated from 1996 to 2010. Mean follow-up is
66 months, with a minimum follow-up of two years. Global pain control is obtained in 81% of patients, with partial improvement
in 12%, thus in only 6% of cases treatment is ineffective. The mean period to obtain these results is 3 months. There are 31% of
relapses, of which more than half recover spontaneously. Side effects on facial sensation, are found in 32%. There are no other
adverse effects or imaging alterations in the brainstem in follow up studies.
Conclusion. The great precision and accuracy of Gamma Knife radiosurgery treatments make it the treatment of choice for trigem-
inal neuralgia, since the target is smaller than 2mm, the proximity to the brainstem critical, and the maximum required doses
for the treatment exceed 80Gy. The excellent clinical results, similar to other published series, support these conclusions.
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